J. Peng

Publications92
h-index18
Citations1,285
Highly Influential Citations55
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • H. Chan
  • 430 Publications, 23,227 Citations
  • H. Janssen
  • 412 Publications, 21,505 Citations
  • P. Marcellin
  • 1,002 Publications, 57,043 Citations
  • J. Sun
  • 134 Publications, 2,393 Citations
  • Publications
  • Influence
Isolation and culture of rat and mouse oligodendrocyte precursor cells
The ability to isolate oligodendroglial precursor cells (OPCs) provides a powerful means to characterize their differentiation, properties and potential for myelin repair. Although much knowledge is… Expand
  • 279
  • 11
  • PDF
Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)
Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China; Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital,… Expand
  • 157
  • 9
  • PDF
Antidiabetic Effect of Oleanolic Acid: A Promising Use of a Traditional Pharmacological Agent
Diabetes mellitus (DM) is a metabolic disorder characterized by chronic hyperglycemia. Although the clear mechanisms of DM and insulin resistance are still to be cleared, it has been well documented… Expand
  • 64
  • 4
  • PDF
Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result
Abstract This study compared virologic response to entecavir monotherapy and de novo lamivudine plus adefovir (LAM + ADV) combination therapy in patients with chronic hepatitis B (CHB) with high… Expand
  • 46
  • 4
Potential effects of telbivudine and entecavir on renal function: a systematic review and meta-analysis
BackgroundTo assess the potential effects of telbivudine (LdT) and entecavir (ETV) on renal function in patients with chronic hepatitis B (CHB), we performed a meta-analysis of the relevant data… Expand
  • 37
  • 3
Larger biopsies evaluation of transient elastography for detecting advanced fibrosis in patients with compensated chronic hepatitis B
Background and Aim:  Although larger biopsies sample had been recommended for the study of non‐invasive liver fibrosis assessment, few studies with larger biopsies for transient elastography (TE)… Expand
  • 22
  • 2
Off-Treatment Hepatitis B Virus (HBV) DNA Levels and the Prediction of Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis B: A Prospective Stop Study
Background The optimal management remains unknown after nucleos(t)ide analogue (NA) discontinuation in patients with chronic hepatitis B (CHB). This prospective study investigated the role of… Expand
  • 28
  • 2
Risk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndrome
Background We investigated whether metabolic syndrome exacerbated the risk of liver fibrosis among chronic hepatitis B patients and risk factors associated with liver steatosis and fibrosis in… Expand
  • 34
  • 2
Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs
Background Patients with chronic hepatitis B virus (HBV) infection who are hepatitis B virus e antigen (HBeAg) positive are increasingly being treated with nucleos(t)ide analogs (NUCs). However, the… Expand
  • 30
  • 2
  • PDF
A comparison of pyogenic liver abscess in patients with or without diabetes: a retrospective study of 246 cases
BackgroundPyogenic liver abscess(PLA) has become common in patients with diabetes mellitus (DM), but it is unclear whether differences exist between patients with and without DM. A retrospective… Expand
  • 8
  • 2